200501_top20shareholders Categories: News & Announcements 2020, Top 20 ShareholdersBy Richard MollardApril 30, 2020Related posts12 May, Phase II Trial – Successful Anti-Cancer OutcomeMay 12, 202030 April, Appendix 3G Notification of Issue, Conversion or Payment of Equity + SecuritiesApril 30, 202020 April, Appendix 4C and Quarterly UpdateApril 20, 202017 April, PharmAust and WEHI evaluate monepantel for COVID-19 in vitroApril 17, 202031 March, Top 20 ShareholdersMarch 31, 202031 March, Expiry of OptionsMarch 31, 2020
30 April, Appendix 3G Notification of Issue, Conversion or Payment of Equity + SecuritiesApril 30, 2020
